Gossamer Bio Inc (FRA:4GB)
€ 0.7705 0.0095 (1.25%) Market Cap: 182.56 Mil Enterprise Value: 39.46 Mil PE Ratio: 0 PB Ratio: 2.46 GF Score: 36/100

Gossamer Bio Inc Investor Day Transcript

Oct 11, 2021 / 06:30PM GMT
Release Date Price: €10.6 (+0.95%)
Operator

Good day, and thank you for standing by, and welcome to the Gossamer Bio CNS-penetrant BTK Investor Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Faheem Hasnain. Please go ahead.

Faheem Hasnain
Gossamer Bio, Inc. - Co-Founder, CEO, President & Chairman

Thank you, operator. Hello, and welcome, everyone, to Gossamer's CNS-Penetrant BTK Investor Day. We appreciate everyone for joining us today. I'd like to draw your attention to the obligatory forward-looking statements. And as a reminder, if you have to leave us early or if you'd like to revisit anything we say here today, a recording will be available on our website at gossamerbio.com as well as a copy of the presentation we're walking through today.

So before we go any further, I'd like to introduce the Gossamer team that you'll be hearing from today. I am Faheem Hasnain, Co-Founder, CEO and Chairman of Gossamer Bio. Laura Carter is our Chief Scientific Officer. Laura has 20 years of industry experience spanning target identification and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot